血液透析機和腹膜透析市場按治療類型、方式、技術、產品類型、最終用戶和患者類型分類－全球預測，2025-2032年

預計到 2032 年，血液透析機和腹膜透析市場規模將達到 1,517.3 億美元，複合年成長率為 6.78%。

本文簡要說明了影響透析治療服務提供和相關人員優先事項的臨床、技術和營運方面的演變因素。

腎衰竭的治療格局正經歷著由技術進步、護理模式轉變、人口結構變化和監管政策調整等因素所驅動的重大變革。儘管血液透析機在許多醫療系統中仍然是腎臟替代療法的基石，但腹膜透析因其以患者為中心的優勢（包括患者自主性和減輕醫療機構負擔）而重新受到青睞。機器自動化、液體處方和血管通路管理方面的進步不斷改進臨床實踐，而基於價值的支付模式和居家照護獎勵也在重塑醫療服務提供者的獎勵。

臨床醫生和營運人員必須平衡當前的臨床需求與長期永續性。這需要整合數位化監測以實現個人化治療，加強供應鏈協作以減少中斷，並重新思考培訓計劃以擴大居家醫療。同時，製造商正在投資模組化平台、改進透析膜和監測系統，以提高效率、安全性和數據連接性。因此，各方相關人員正在調整策略，以應對不斷變化的患者偏好、監管要求和競爭格局，同時保持高標準的臨床療效和營運可靠性。

家庭優先策略、先進醫療設備的應用以及對永續性的需求如何重塑醫療服務模式、醫療服務提供者的優先事項和支付方的獎勵

透析領域正經歷一場變革性的轉變，而這場轉變影響著臨床路徑、治療地點以及供應商生態系統。家庭透析治療的日益普及是其中最顯著的變化之一，這得益於人體工學設備的改進、遠端患者監護技術的進步以及結構化看護者培訓計畫的完善。向居家照護的轉變正在改變透析的使用模式，催生了對小型化、易用型設備的需求，並重新定義了服務模式，更加重視遠端支援和物流。

另一個變革性趨勢是選擇性地採用先進的透析技術，例如線上血液透析濾過和更先進的透析設備遙測技術。這些創新為特定患者群體帶來了差異化的臨床療效，並促使支付方和醫療服務提供者重新審視通訊協定和報銷模式。同時，對永續性和成本控制的日益重視，推動了更廢棄物的濃縮液、在臨床適用情況下可重複使用的組件以及全生命週期籌資策略。總而言之，這些變化正促使製造商加快產品差異化，促使醫療服務提供者重塑治療路徑，並促使政策制定者重新評估獎勵。

全面評估2025年關稅改革如何改變透析價值鏈的採購、籌資策略和產品設計。

2025年美國關稅政策正影響透析價值鏈各環節的採購決策、供應商網路和成本結構。進口關稅和關稅主導的監管調整使得籌資策略更加重要，迫使醫療系統和製造商重新評估供應商多元化、近岸外包和庫存管理政策。這些變化尤其影響那些傳統上在國際供應中扮演核心角色、包含眾多組件的產品類型，例如透析設備、監控系統和管路組件。

為應對不斷上漲的進口成本和日益複雜的合規流程，許多公司正在加快關鍵製造流程的本地化進程，重新談判長期供應商契約，並重新設計產品物料材料清單，以降低關稅的影響。供應商則透過重新考慮融資時機，並加強以價值為基礎的合約來應對，這些合約會考慮包括物流和關稅相關費用在內的總擁有成本。同時，企業的創新策略也受到影響，轉向模組化設計和不易受關稅影響的替代原料。累積作用，導致商業性模式的重塑，更加強調供應鏈的透明度和合約的彈性。

精準的細分主導智慧，將臨床模式、產品屬性、終端用戶管道和病患群體與最佳化目標定位的策略要務連結起來

細分市場層面的洞察揭示了不同治療類型、模式、技術、產品、終端使用者和患者群體之間的差異化動態，有助於制定有針對性的策略方法。基於治療類型，血液透析機和腹膜透析的比較突顯了二者在運作規模和病患體驗上的差異。在腹膜透析領域，自動化腹膜透析和持續性非臥床腹膜透析之間的模式差異會影響設備的複雜性、訓練強度以及遠端監測的需求。基於模式，家庭透析治療透析和中心透析之間的差異影響著從資金分配到人員配備模式的方方面面，而家庭透析治療類別又可根據輔助照護和自我護理路徑進一步細分。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

• 整合遠端患者監護技術的家用血液透析機系統正日益普及
• 穿戴式人工腎臟裝置為末期腎臟病患者提供便攜性和持續透析。
• 永續透析液回收和水淨化創新技術，以減少透析中心的資源消耗
• 整合人工智慧驅動的預測分析，以最佳化透析治療方案和個人化護理計劃
• 有利的政府報銷政策推動了新興市場腹膜透析的擴張。
• 開發生物相容性透析膜，以最大限度減少發炎反應並改善患者預後。
• 可攜式腹膜透析週期計可提高患者在各種護理環境中的活動能力和獨立性。
• 遠端醫療的病人參與平台可提高家庭透析治療治療的依從性和療效。
• 策略性醫療器材和生物製藥合作，開發針對末期腎病併發症的新治療方法
• 符合環保法規並排放醫療廢棄物的環保一次性透析產品

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 按治療類型分類的血液透析機和腹膜透析市場

• 血液透析機
• 腹膜透析
  • 自動腹膜透析
  • 持續性攜帶式腹膜透析

第9章血液透析機/腹膜透析市場：依透析方式分類

• 家
  • 輔助護理
  • 自我治療
• 中心內部

第10章 按技術分類的血液透析機和腹膜透析市場

• 傳統血液透析機
• 線上血液透析機
  • 混合流
  • 替代流

第11章 依產品類型分類的血液透析機和腹膜透析市場

• 濃縮液
• 透析設備
• 透析器
  • 高通量
  • 低通量
• 監控系統
• 管組

第12章 依最終用戶分類的血液透析機和腹膜透析市場

• 透析中心
• 居家照護機構
• 醫院
• 專科診所

第13章 依病患類型分類的血液透析機和腹膜透析市場

• 成人
• 老年人
• 孩子們

第14章 按地區分類的血液透析機和腹膜透析市場

• 美洲
  • 北美洲
  • 拉丁美洲
• 歐洲、中東和非洲
  • 歐洲
  • 中東
  • 非洲
• 亞太地區

第15章 按組別分類的血液透析機和腹膜透析市場

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第16章 各國血液透析機及腹膜透析市場

• 美國
• 加拿大
• 墨西哥
• 巴西
• 英國
• 德國
• 法國
• 俄羅斯
• 義大利
• 西班牙
• 中國
• 印度
• 日本
• 澳洲
• 韓國

第17章 競爭格局

• 2024年市佔率分析
• FPNV定位矩陣，2024
• 競爭分析
  • Fresenius Medical Care AG & Co. KGaA
  • DaVita Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Nipro Corporation
  • Toray Industries, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • Diaverum AB
  • Jafron Biomedical Co., Ltd.
  • NxStage Medical, Inc.

The Hemodialysis & Peritoneal Dialysis Market is projected to grow by USD 151.73 billion at a CAGR of 6.78% by 2032.

A concise orientation to the evolving clinical, technological, and operational forces reshaping dialysis care delivery and stakeholder priorities

The treatment landscape for kidney failure is undergoing a meaningful evolution driven by technology, shifting care models, demographic pressures, and regulatory recalibrations. Hemodialysis remains a cornerstone of renal replacement therapy delivery in many health systems, while peritoneal dialysis is gaining renewed attention because of patient-centric advantages such as autonomy and reduced facility burden. Advances in machine automation, fluid formulations, and vascular access management continue to refine clinical practice, even as value-based payment models and home-care incentives reshape provider incentives.

Clinicians and operators must balance acute clinical imperatives with long-term sustainability. This means integrating digital monitoring to personalize therapy, strengthening supply chain partnerships to mitigate disruption, and rethinking training programs to scale home-based modalities. At the same time, manufacturers are investing in modular platforms, improved dialyzer membranes, and monitoring systems that enhance efficiency, safety, and data connectivity. As a result, stakeholders across the continuum are retooling strategies to meet changing patient preferences, regulatory expectations, and competitive dynamics, while preserving high standards of clinical effectiveness and operational reliability.

How home-first strategies, advanced device adoption, and sustainability imperatives are jointly rewriting care delivery models, supplier priorities, and payer incentives

The dialysis landscape is experiencing transformative shifts that affect clinical pathways, care delivery locations, and supplier ecosystems. Increasing acceptance of home modalities is one of the most consequential changes, supported by improvements in device ergonomics, remote patient monitoring, and structured caregiver training programs. This migration toward home-based care alters utilization patterns, creates demand for compact, user-friendly devices, and redefines service models to emphasize remote support and logistics.

Another transformative trend is the selective adoption of advanced dialysis technologies such as online hemodiafiltration and more sophisticated dialysis machine telemetry. These innovations are introducing differentiated clinical outcomes for specific patient cohorts and prompting payers and providers to consider revised protocols and reimbursement models. Concurrently, there is intensified focus on sustainability and cost containment, encouraging adoption of low-waste concentrates, reusable components where clinically appropriate, and lifecycle procurement strategies. Collectively, these shifts are prompting manufacturers to accelerate product differentiation, providers to reconfigure care pathways, and policymakers to revisit regulations and incentives that influence where and how dialysis care is delivered.

An integrated assessment of how tariff changes enacted in 2025 have reshaped procurement, sourcing strategy, and product design across the dialysis value chain

The tariff landscape introduced in the United States in 2025 has influenced procurement decisions, supplier networks, and cost structures across the dialysis value chain. Import duties and tariff-driven regulatory adjustments have contributed to increased attention on sourcing strategies, prompting health systems and manufacturers to re-evaluate supplier diversification, nearshoring, and inventory management policies. These shifts have had particular resonance for component-heavy product categories such as dialysis machines, monitoring systems, and tubing sets where international supply streams historically play a central role.

As organizations adjust to elevated import costs and compliance complexity, many have accelerated efforts to localize key manufacturing steps, renegotiate long-term supplier agreements, and redesign product bill-of-materials to reduce tariff exposure. Providers have responded by reassessing capital procurement timing and by intensifying value-based contracting conversations that account for total cost of ownership, including logistics and tariff-related expenses. Simultaneously, innovation strategies have been influenced as companies target modular designs and alternative raw materials to limit tariff sensitivity. The cumulative effect is a reconfiguration of commercial playbooks and an increased premium on supply chain transparency and contractual resilience.

Precise segmentation-driven intelligence linking clinical modality, product characteristics, end-user channels, and patient cohorts to strategic imperatives for optimized targeting

Segment-level insights reveal differentiated dynamics across treatment type, modality, technology, product, end-user, and patient cohorts that inform targeted strategic approaches. Based on Treatment Type, the comparative trajectories of Hemodialysis and Peritoneal Dialysis highlight contrasting operational footprints and patient experience profiles; within Peritoneal Dialysis, the distinctions between Automated Peritoneal and Continuous Ambulatory Peritoneal modalities influence device complexity, training intensity, and remote-monitoring needs. Based on Modality, the home versus in-center divide frames everything from capital allocation to staffing models, with the Home category further differentiated by Assisted Care and Self Care pathways that carry distinct clinical governance and reimbursement implications.

Based on Technology, the split between Conventional Hemodialysis and Online Hemodiafiltration underscores differing clinical evidence bases and infrastructure requirements, while the latter's Mixed Flow and Substitution Flow variants create nuanced clinical and capital considerations for adoption. Based on Product Type, categories such as Concentrates Fluids, Dialysis Machines, Dialyzers, Monitoring Systems, and Tubing Sets each follow separate innovation and regulatory timelines, and within Dialyzers the High Flux and Low Flux subtypes carry implications for therapy customization and supply inventory planning. Based on End User, distribution and service models vary significantly among Dialysis Centers, Home Care Settings, Hospitals, and Specialty Clinics, shaping commercial channels and aftermarket services. Based on Patient Type, distinct clinical pathways and device configurations are required for Adult, Geriatric, and Pediatric populations, affecting training protocols, dosing algorithms, and caregiver supports. Taken together, these segmentation lenses permit granular prioritization of investments, tailored go-to-market tactics, and differentiated clinical support programs that align with both patient needs and organizational capabilities.

How regional healthcare structures, reimbursement diversity, and supply chain realities are shaping differentiated adoption paths and go-to-market priorities globally

Regional dynamics continue to exert a defining influence on technology adoption, reimbursement mechanisms, and operational models across dialysis care. In the Americas, health system consolidation, established dialysis provider networks, and policy emphasis on value-based care drive demand for scalable in-center efficiency tools and a growing interest in home dialysis models that reduce facility burden. In contrast, Europe, Middle East & Africa present a mosaic of reimbursement environments and regulatory frameworks that influence adoption cadence for advanced technologies, with pockets of rapid uptake in markets that prioritize chronic disease management and remote care infrastructure.

Asia-Pacific encompasses a range of healthcare maturity levels, from advanced systems investing in digital health and localized manufacturing to emerging markets where access, affordability, and workforce constraints limit rapid modality transitions. Across regions, supply chain strategies, tariff exposure, and local manufacturing incentives influence product availability and pricing dynamics. The practical implication is that manufacturers and providers must calibrate regional go-to-market strategies, regulatory engagement, and service delivery models to the specific reimbursement incentives, infrastructure readiness, and patient population characteristics of each geography.

Competitive behaviors and strategic investments reveal a clear pivot toward integrated product-service platforms, clinical evidence generation, and regional capability expansion

Leading companies in the dialysis ecosystem are pursuing a mix of clinical differentiation, platform consolidation, and service-based models to sustain growth and defend margins. Product innovation focuses on smaller, more intuitive home devices, advanced dialyzer materials that improve biocompatibility and clearance, and integrated monitoring systems that enable remote titration of therapy and earlier intervention. Companies are also expanding service portfolios to include training programs, logistics management, and outcomes-based partnerships with providers, reflecting recognition that durable value often lies in the interplay between device performance and continuous clinical support.

Strategic alliances and selective acquisitions remain active pathways to accelerate capability-building, particularly in digital health, disposables manufacturing, and regional distribution. Firms are investing in real-world evidence generation to support differentiated clinical claims and payer negotiations, while also optimizing aftermarket service and consumables revenue streams. The competitive landscape rewards organizations that can combine robust clinical data, regulatory agility, and operational excellence to deliver seamless patient journeys across in-center and home settings.

Actionable strategic priorities for manufacturers, providers, payers, and supply chain leaders to strengthen resilience and accelerate modality transitions

Industry leaders should prioritize a set of targeted actions to navigate current headwinds and capture emerging opportunities across the dialysis continuum. Manufacturers ought to accelerate modular design initiatives that reduce reliance on tariff-sensitive components and simplify field servicing, while simultaneously enhancing digital telemetry to support remote monitoring and predictive maintenance. Providers should expand home modality programs through rigorous training curriculums, caregiver support frameworks, and partnership-based care pathways that lower barriers to patient uptake. Payers and policymakers can meaningfully influence adoption by calibrating reimbursement policies to reward outcomes and enable scalable home care delivery.

Supply chain leaders should pursue supplier diversification and nearshoring where feasible to reduce exposure to tariff volatility and logistical bottlenecks, and should increase investments in inventory analytics to balance cost and clinical readiness. Commercial teams must refine value propositions that articulate total cost of care and clinical outcomes rather than focusing on unit price alone, thereby enabling longer-term contracting that absorbs short-term tariff fluctuations. Finally, all stakeholders should commit to robust data governance and interoperability standards to ensure patient safety, facilitate remote care, and accelerate evidence generation that supports appropriate therapy selection.

A transparent synthesis of secondary evidence, targeted primary interviews, and rigorous data triangulation to ensure credible and actionable insights

The research underpinning this report combines systematic secondary review with structured primary engagement to ensure balanced, verifiable insights. The secondary phase incorporated peer-reviewed clinical literature, regulatory filings, device technical specifications, and policy documents to establish a baseline understanding of clinical practice and technology performance. This foundation was augmented by primary interviews with a cross-section of stakeholders including clinicians, procurement leaders, device engineers, and payers to validate trends, capture operational realities, and surface emerging commercial behaviors.

Data triangulation techniques were applied to reconcile discrepancies between reported performance claims, regulatory documentation, and frontline user experiences. Segmentation frameworks were iteratively refined to reflect clinically meaningful distinctions across treatment type, modality, technology, product, end-user, and patient cohorts. Limitations are acknowledged with transparency: where evidence was sparse, findings were flagged as emergent and recommendations were framed to accommodate scenario-based planning. Ethical considerations guided respondent confidentiality and conflict-of-interest screening during primary engagement to preserve the integrity of conclusions.

A definitive synthesis of clinical, technological, and commercial signals that highlights decisive pathways to sustainable growth and improved patient outcomes

The dialysis sector stands at an inflection point characterized by converging technological innovation, shifting care delivery models, and heightened operational complexity. Home modalities, fueled by device miniaturization and remote monitoring, present a compelling alternative to facility-centric care for many patients, while advanced therapies and materials are refining clinical capabilities for selected cohorts. At the same time, policy changes and tariff dynamics are reshaping procurement and manufacturing priorities, compelling stakeholders to adopt more resilient, agile strategies.

Looking ahead, organizations that invest in integrated product-service offerings, strengthen regional supply chain resilience, and generate robust real-world evidence are positioned to lead. Collaboration among manufacturers, providers, payers, and regulators will be essential to harmonize incentives and accelerate adoption of care models that improve patient experience while containing system costs. In short, success will depend on the ability to translate emerging clinical and technological promise into scalable, economically viable care pathways that meet the needs of diverse patient populations.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Rising adoption of home-based hemodialysis systems integrated with remote patient monitoring technologies
• 5.2. Wearable artificial kidney devices advancing portability and continuous dialysis for end-stage renal disease patients
• 5.3. Sustainable dialysate recycling and water purification innovations to reduce resource consumption in dialysis centers
• 5.4. Integration of AI-driven predictive analytics to optimize dialysis treatment schedules and personalized care plans
• 5.5. Expansion of peritoneal dialysis in emerging markets driven by favorable government reimbursement policies
• 5.6. Development of biocompatible dialysis membranes minimizing inflammatory responses and improving patient outcomes
• 5.7. Portable peritoneal dialysis cyclers enhancing patient mobility and independence across diverse care settings
• 5.8. Telehealth-enabled patient engagement platforms improving adherence and outcomes in home-based dialysis therapies
• 5.9. Strategic device and biopharma partnerships for developing novel therapies targeting end-stage kidney disease complications
• 5.10. Eco-friendly single-use dialysis products addressing environmental regulations and reducing medical waste footprint

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Hemodialysis & Peritoneal Dialysis Market, by Treatment Type

• 8.1. Hemodialysis
• 8.2. Peritoneal Dialysis
  • 8.2.1. Automated Peritoneal
  • 8.2.2. Continuous Ambulatory Peritoneal

9. Hemodialysis & Peritoneal Dialysis Market, by Modality

• 9.1. Home
  • 9.1.1. Assisted Care
  • 9.1.2. Self Care
• 9.2. In Center

10. Hemodialysis & Peritoneal Dialysis Market, by Technology

• 10.1. Conventional Hemodialysis
• 10.2. Online Hemodiafiltration
  • 10.2.1. Mixed Flow
  • 10.2.2. Substitution Flow

11. Hemodialysis & Peritoneal Dialysis Market, by Product Type

• 11.1. Concentrates Fluids
• 11.2. Dialysis Machines
• 11.3. Dialyzers
  • 11.3.1. High Flux
  • 11.3.2. Low Flux
• 11.4. Monitoring Systems
• 11.5. Tubing Sets

12. Hemodialysis & Peritoneal Dialysis Market, by End User

• 12.1. Dialysis Centers
• 12.2. Home Care Settings
• 12.3. Hospitals
• 12.4. Specialty Clinics

13. Hemodialysis & Peritoneal Dialysis Market, by Patient Type

• 13.1. Adult
• 13.2. Geriatric
• 13.3. Pediatric

14. Hemodialysis & Peritoneal Dialysis Market, by Region

• 14.1. Americas
  • 14.1.1. North America
  • 14.1.2. Latin America
• 14.2. Europe, Middle East & Africa
  • 14.2.1. Europe
  • 14.2.2. Middle East
  • 14.2.3. Africa
• 14.3. Asia-Pacific

15. Hemodialysis & Peritoneal Dialysis Market, by Group

• 15.1. ASEAN
• 15.2. GCC
• 15.3. European Union
• 15.4. BRICS
• 15.5. G7
• 15.6. NATO

16. Hemodialysis & Peritoneal Dialysis Market, by Country

• 16.1. United States
• 16.2. Canada
• 16.3. Mexico
• 16.4. Brazil
• 16.5. United Kingdom
• 16.6. Germany
• 16.7. France
• 16.8. Russia
• 16.9. Italy
• 16.10. Spain
• 16.11. China
• 16.12. India
• 16.13. Japan
• 16.14. Australia
• 16.15. South Korea

17. Competitive Landscape

• 17.1. Market Share Analysis, 2024
• 17.2. FPNV Positioning Matrix, 2024
• 17.3. Competitive Analysis
  • 17.3.1. Fresenius Medical Care AG & Co. KGaA
  • 17.3.2. DaVita Inc.
  • 17.3.3. B. Braun Melsungen AG
  • 17.3.4. Baxter International Inc.
  • 17.3.5. Nipro Corporation
  • 17.3.6. Toray Industries, Inc.
  • 17.3.7. Asahi Kasei Medical Co., Ltd.
  • 17.3.8. Diaverum AB
  • 17.3.9. Jafron Biomedical Co., Ltd.
  • 17.3.10. NxStage Medical, Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2032 (%)
• FIGURE 13. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. MIDDLE EAST HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. ASEAN HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. GCC HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. EUROPEAN UNION HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. BRICS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. G7 HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. NATO HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 30. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 31. HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 32. HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY AUTOMATED PERITONEAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONTINUOUS AMBULATORY PERITONEAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, BY REGION, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, BY REGION, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ASSISTED CARE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ASSISTED CARE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ASSISTED CARE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ASSISTED CARE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ASSISTED CARE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ASSISTED CARE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SELF CARE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SELF CARE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SELF CARE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SELF CARE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SELF CARE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SELF CARE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY IN CENTER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY IN CENTER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY IN CENTER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY IN CENTER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY IN CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY IN CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONVENTIONAL HEMODIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MIXED FLOW, BY REGION, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MIXED FLOW, BY REGION, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MIXED FLOW, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MIXED FLOW, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MIXED FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MIXED FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBSTITUTION FLOW, BY REGION, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBSTITUTION FLOW, BY REGION, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBSTITUTION FLOW, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBSTITUTION FLOW, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBSTITUTION FLOW, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBSTITUTION FLOW, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONCENTRATES FLUIDS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONCENTRATES FLUIDS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONCENTRATES FLUIDS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONCENTRATES FLUIDS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONCENTRATES FLUIDS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY CONCENTRATES FLUIDS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS MACHINES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS MACHINES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS MACHINES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS MACHINES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HIGH FLUX, BY REGION, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HIGH FLUX, BY REGION, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HIGH FLUX, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HIGH FLUX, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HIGH FLUX, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HIGH FLUX, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY LOW FLUX, BY REGION, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY LOW FLUX, BY REGION, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY LOW FLUX, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY LOW FLUX, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY LOW FLUX, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY LOW FLUX, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MONITORING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MONITORING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MONITORING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MONITORING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MONITORING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TUBING SETS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TUBING SETS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TUBING SETS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TUBING SETS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TUBING SETS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TUBING SETS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GERIATRIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 183. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 184. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 185. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
• TABLE 186. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
• TABLE 187. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
• TABLE 188. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2032 (USD MILLION)
• TABLE 189. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
• TABLE 190. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
• TABLE 191. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2024 (USD MILLION)
• TABLE 192. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2025-2032 (USD MILLION)
• TABLE 193. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 194. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 195. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2024 (USD MILLION)
• TABLE 196. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2025-2032 (USD MILLION)
• TABLE 197. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 198. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 199. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2024 (USD MILLION)
• TABLE 200. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2025-2032 (USD MILLION)
• TABLE 201. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 202. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 203. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
• TABLE 204. AMERICAS HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
• TABLE 205. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 206. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 207. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
• TABLE 208. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
• TABLE 209. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
• TABLE 210. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2032 (USD MILLION)
• TABLE 211. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
• TABLE 212. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
• TABLE 213. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2024 (USD MILLION)
• TABLE 214. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2025-2032 (USD MILLION)
• TABLE 215. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 216. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 217. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2024 (USD MILLION)
• TABLE 218. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2025-2032 (USD MILLION)
• TABLE 219. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 220. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 221. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2024 (USD MILLION)
• TABLE 222. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2025-2032 (USD MILLION)
• TABLE 223. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 224. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 225. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
• TABLE 226. NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
• TABLE 227. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 228. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 229. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
• TABLE 230. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
• TABLE 231. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
• TABLE 232. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2032 (USD MILLION)
• TABLE 233. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
• TABLE 234. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
• TABLE 235. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2024 (USD MILLION)
• TABLE 236. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2025-2032 (USD MILLION)
• TABLE 237. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 238. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 239. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2024 (USD MILLION)
• TABLE 240. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2025-2032 (USD MILLION)
• TABLE 241. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 242. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 243. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2024 (USD MILLION)
• TABLE 244. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2025-2032 (USD MILLION)
• TABLE 245. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 246. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 247. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
• TABLE 248. LATIN AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
• TABLE 249. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 250. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 251. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
• TABLE 252. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
• TABLE 253. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
• TABLE 254. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2032 (USD MILLION)
• TABLE 255. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
• TABLE 256. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
• TABLE 257. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2024 (USD MILLION)
• TABLE 258. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2025-2032 (USD MILLION)
• TABLE 259. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 260. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 261. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2018-2024 (USD MILLION)
• TABLE 262. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY ONLINE HEMODIAFILTRATION, 2025-2032 (USD MILLION)
• TABLE 263. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 264. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 265. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2018-2024 (USD MILLION)
• TABLE 266. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY DIALYZERS, 2025-2032 (USD MILLION)
• TABLE 267. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 268. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 269. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
• TABLE 270. EUROPE, MIDDLE EAST & AFRICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
• TABLE 271. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 272. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 273. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
• TABLE 274. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TREATMENT TYPE, 2025-2032 (USD MILLION)
• TABLE 275. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2018-2024 (USD MILLION)
• TABLE 276. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY PERITONEAL DIALYSIS, 2025-2032 (USD MILLION)
• TABLE 277. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
• TABLE 278. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
• TABLE 279. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2018-2024 (USD MILLION)
• TABLE 280. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY HOME, 2025-2032 (USD MILLION)
• TABLE 281. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 282. EUROPE HEMODIALYSIS & PERITONEAL DIALYSIS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (US